Asymmetric Synthesis of a Small Molecule Inhibitor of TNFα via Enantioenriched 4-Substituted Tetrahydroisoquinolines
Organic Letters · 13.11.2026
DOI: 10.1021/acs.orglett.6c04407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 13.11.2026. Verfasst von Stephen N. Greszler und 3 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: AbbVie.
Abstract (Originalsprache)
An improved decagram-scale enabling asymmetric synthesis of a lead small molecule inhibitor of TNFα is described. An overall >15-fold improvement in yield compared to the original route was accomplished through the development of a new chromatography-free enantioselective sequence that delivered >20 g of the target compound. Highlights of the new route include an efficient Parham cyclization that rapidly afforded hectagram quantities of a key dihydroisoquinolone, an uncommon asymmetric synthesis of 4-hydroxy and 4-amino tetrahydroisoquinoline intermediates, and improved Cu-free access to the unique heterocycle-rich pentacyclic scaffold.
Förderung
- AbbVie
Zitieren
APA
Greszler, S. N., Altenbach, R. J., Gfesser, G. A., & Voight, E. A. (2026). Asymmetric Synthesis of a Small Molecule Inhibitor of TNFα via Enantioenriched 4-Substituted Tetrahydroisoquinolines. Organic Letters. https://doi.org/10.1021/acs.orglett.6c04407
Vancouver
Greszler SN, Altenbach RJ, Gfesser GA, Voight EA. Asymmetric Synthesis of a Small Molecule Inhibitor of TNFα via Enantioenriched 4-Substituted Tetrahydroisoquinolines. Organic Letters. 2026. doi:10.1021/acs.orglett.6c04407
BibTeX
@article{Greszler2026,
author = {Greszler, Stephen N. and Altenbach, Robert J. and Gfesser, Gregory A. and Voight, Eric A.},
title = {Asymmetric Synthesis of a Small Molecule Inhibitor of TNFα via Enantioenriched 4-Substituted Tetrahydroisoquinolines},
journal = {Organic Letters},
year = {2026},
doi = {10.1021/acs.orglett.6c04407}
}
EUVIMED